Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2004 Oct 18:3:35.
doi: 10.1186/1475-2875-3-35.

Association of house spraying with suppressed levels of drug resistance in Zimbabwe

Affiliations
Multicenter Study

Association of house spraying with suppressed levels of drug resistance in Zimbabwe

Sungano Mharakurwa et al. Malar J. .

Abstract

Background: Public health strategies are needed to curb antimalarial drug resistance. Theoretical argument points to an association between malaria transmission and drug resistance although field evidence remains limited. Field observations, made in Zimbabwe, on the relationship between transmission and multigenic drug resistance, typified by chloroquine, are reported here.

Methods: Periodic assessments of the therapeutic response of uncomplicated falciparum malaria to chloroquine in two selectively sprayed or unsprayed health centre catchments, from 1995 - 2003. Cross-sectional analysis of in vivo chloroquine failure events for five sites in relation to natural endemicity and spraying history.

Results: During selective house spraying, the chloroquine failure rate for the sprayed catchment decreased, such that, after four years, the odds of chloroquine failure were 4x lower than before start of spraying in the area (OR 0.2, 95% CI 0.07 - 0.75, p = 0.010, n = 100). Chloroquine failure odds for the sprayed area became 4x lower than contemporaneous failure odds for the unsprayed area (OR 0.2 95% CI 0.08 - 0.65, p = 0.003, n = 156), although the likelihood of failure was not significantly different for the two catchments before selective spraying started (OR 0.5, 95% CI 0.21 - 1.32; p = 0.170, n = 88). When spraying ended, in 1999, the drug failure odds for the former sprayed area increased back 4 fold by 2003 (OR 4.2, 95%CI 1.49 - 11.78, p = 0.004, n = 146). High altitude areas with naturally lower transmission exhibited a 6x lower likelihood of drug failure than low-lying areas (OR 0.16 95% CI 0.068 - 0.353, -2 log likelihood change 23.239, p < 0.001, n = 465). Compared to sites under ongoing annual spraying, areas that were last sprayed 3-7 years ago experienced a 4-fold higher probability of chloroquine failure (OR 4.1, 95%CI 1.84 - 9.14, -2 log likelihood change 13.956, p < 0.001).

Conclusion: Reduced transmission is associated with suppressed levels of resistance to chloroquine and presumably other regimens with multigenic drug resistance. It seems the adoption of transmission control alongside combination chemotherapy is a potent strategy for the future containment of drug-resistant malaria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Location of study sites, shown in relation to altitudinal zones that govern malaria endemicity. Central watershed (elevation > 1200 m above sea level) experiences nil – hypoendemic malaria transmission, and endemicity increases with falling altitude towards the north and south of the country.
Figure 2
Figure 2
Monthly malarial incidence in Burma valley (BV) and Sahumani (SH) catchments during and after selective spraying (boxed terms, Risk Ratios (95% CI) for peak malaria transmission period (February – May)).
Figure 3
Figure 3
Distribution of mutated (m) and wild (w) P. falciparum variants in Burma Valley (BV) and Sahumani (SH), at Pfmdr1 codons 86 (Pfmdr-86) and 1246 (Pfmdr-1246), and Pfcrt codon 76 (Pfcrt-76).
Figure 4
Figure 4
Scatter plot of therapeutic failure prevalence with malarial incidence.
Figure 5
Figure 5
Monthly malarial incidence per thousand population in hyperendemic (hyper) and mesoendemic (meso) catchments.

Similar articles

Cited by

References

    1. Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther. 1991;50:95–121. doi: 10.1016/0163-7258(91)90074-V. - DOI - PubMed
    1. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop. 1994;56:143–156. doi: 10.1016/0001-706X(94)90060-4. - DOI - PubMed
    1. D'Alessandro U, Buttiens H. History and importance of antimalarial drug resistance. Trop Med Int Health. 2001;6:845–848. doi: 10.1046/j.1365-3156.2001.00819.x. - DOI - PubMed
    1. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:12–17. - PubMed
    1. Trape JF, Pison G, Spiegel A, Enel C, Rogier C. Combating malaria in Africa. Trends Parasitol. 2002;18:224–230. doi: 10.1016/S1471-4922(02)02249-3. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources